Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastrointestinal Stromal Tumors × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 31 Kidney Neoplasms 9 Neoplasm Metastasis 6 Melanoma 5 Neoplasms 4 Glioblastoma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Recurrence 3 Clear-cell metastatic renal cell carcinoma 3 Sarcoma 2 Liver Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 cT2a N0NxM0 Renal Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Solid Malignancies 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Relapsed Pediatric Solid Tumor 1 Radiation Therapy 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroendocrine Tumors 1

Interventions

Imatinib Mesylate 29 Sunitinib 8 regorafenib 7 Laparoscopy 4 Dasatinib 4 Blood Specimen Collection 4 pazopanib 3 nilotinib 3 Surveys and Questionnaires 3 Observation 3 spartalizumab 2 ripretinib 2 binimetinib 2 apatinib 2 Temozolomide 2 Surgical Procedures, Operative 2 Paclitaxel 2 Neoadjuvant Therapy 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Capecitabine 2 Biopsy, Fine-Needle 2 Biopsy 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 vatalanib 1 trametinib 1 sargramostim 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04258956 2025-09-11

AXAGIST

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡